Eficacia de los sellados sistemáticos de catéter con taurolidina/heparina versus taurolidina/uroquinasa en pacientes con insuficiencia renal crónica estadio 5D

Fontseré, Néstor; Soriano, Alex; Mestres, Gaspar; Bermudez, Patricia; Zarco, Federico; Lozano, Valentín; Rodas, Lida; Broseta, Jose; Arias, Marta; Maduell, Francisco.
Nefrología (Madrid) ; 42(5): 611-613, sept.-oct. 2022. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-211259

Documentos relacionados

  1. Improving assessment and escalation of threatened haemodialysis access: results of a nursing-led program.
  2. Brachiocephalic and Radiocephalic Arteriovenous Fistulas in Patients with Tunneled Dialysis Catheters Have Similar Outcomes.
  3. Hemodialysis vascular access coordinator: Three-level model for access management.
  4. Hemodialysis Arteriovenous Fistula Dysfunction: Retrospective Comparison of Post-thrombotic Percutaneous Endovascular Interventions with Pre-emptive Angioplasty.
  5. The Light Chain Allosterically Enhances the Protease Activity of Murine Urokinase-Type Plasminogen Activator.
  6. [Comparative study between 20 IU/ml heparin and 5% heparin/urokinase 5000 IU lock in hemodialysis central venous catheters with permeability problems].
  7. Rational peptide design for targeting cancer cell invasion.
  8. The rare complication caused by thrombus shedding during arteriovenous fistula thrombolysis: a case report.
  9. Swing segment stenosis: An unresolved challenge.
  10. A new hope for vascular access, modifying a new technique: The Surfacer® Inside-Out Access Catheter System and sharp recanalization.